Randox Health First to Offer Tasso’s Patient-Centric Remote Sampling Device
This partnership combines Randox Health’s expansive at-home testing capabilities with Tasso’s innovative and virtually painless blood sample collection solutions.
November 28, 2023 – Randox Health, which provides at-home and in-clinic health tests as part of Randox – the largest healthcare diagnostics company in the UK and Ireland – and Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, today announced a partnership to offer at-home healthcare diagnostic testing powered by Tasso’s innovative blood collection technology.
Randox Health offers more than 10 at-home testing kits for a variety of health concerns, and is the first major laboratory in the UK to validate the Tasso devices and offer them to consumers for at-home health and wellness diagnostic testing. Through the partnership, people using Randox Health at-home tests will have access to Tasso’s innovative portfolio of convenient, virtually painless blood collection device with pre-order availability for the device via their male & female hormone test kits in December.
“As part of our mission to transform preventative healthcare and enable consumers to take control of their health through quality data, we are thrilled to partner with Tasso to make it easier, more convenient and less painful for people to access critical health information,” said Alexander Rusak, Vice President of Sales at Randox Health. “By offering Tasso’s devices for clinical-grade blood sample collection as part of our testing kits – available through our website or at our clinic storefronts – we are providing an improved experience and addressing consumer needs.”
By combining Tasso’s technical expertise and Randox Health’s in-depth industry knowledge across key areas, including hormonal health, female health, genetics, and others, customers can benefit from receiving real-time insights about their health, enabling them to monitor and improve their overall well-being.
“Tasso and Randox Health share a vision of increasing access to healthcare with patient-centric solutions and accelerating convenient, at-home healthcare options,” said Ben Casavant, PhD, CEO and co-founder of Tasso, Inc. “By offering our devices as part Randox Health’s at-home testing kits, we hope to not only improve the patient experience, but also provide information that can allow individuals to make better informed decisions about their health.”
About Randox Health
Established in 1982, Randox is the largest healthcare diagnostics company from the UK & Ireland. Randox focusses on the provision of timely and accurate testing to identify risks to health, improve clinical diagnosis and promote preventative healthcare; aiming to achieve better healthcare outcomes, whilst reducing the burden on clinical services. Randox Health Clinics are based throughout the UK & Ireland, enabling easy-access for millions of people to a new range of preventative health packages designed to help clients take control of their health.
For more information, please visit randoxhealth.com
About Tasso
Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders. For more information, please visit www.tassoinc.com.
Media Contacts:
Lynsey Adams
Randox Health
Dina Schneider
Tasso, Inc.
(206) 822-4186 x1016